Cipla, Hetero, and Jubilant Lifesciences have signed voluntary licensing agreements with Gilead.

Use of remdesivir is said to reduce hospital stay by 31 per cent to 11 days from 15 days.

The US has given emergency approval to use the antiviral drug for the treatment of critical Covid-19 patients.

In India, people familiar with the development said the company is in discussions with Dr Reddy’s Laboratories, Cipla, Jubilant Lifescience...

Even as Hamied prepares genext leaders for Cipla, it’s humanitarian face is out to shake up industry by delivering affordable biosimilar dr...

On the face of it, there is nothing wrong with this kind of a deal. Pharma companies ink many such pacts on a regular basis.

Hyderabad based Hetero labs through an agreement with Geneva based Medicines Patent Pool will produce four key HIV drugs developed by Gilea...

Prices of popular anti-Aids medicine Tenofovir could soon fall as several Indian drug companies plan to launch their low-cost versions in t...

Pharmaceutical companies in India seem to be conducting a few experiments outside their labs too.